Pretargeting strategies for radio-immunoguided tumour localisation and therapy

European Journal of Cancer Part A

Volumn 33, Issue 2, 1997, Pages 186-192

  Stoldt, H S ^a   Aftab, F ^a   Chinol, M ^a   Paganelli, G ^a   Luca, F ^a   Testori, A ^a   Geraghty, J G ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Avidin biotin; Immunoscintigraphy; Monoclonal antibody; Pretargeting; Radio immunotherapy

Indexed keywords

MONOCLONAL ANTIBODY; RADIOISOTOPE;

CANCER; DRUG TARGETING; HUMAN; IMMUNOSCINTIGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; REVIEW;

ANTIBODIES, MONOCLONAL; HUMANS; NEOPLASMS; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY;

EID: 0030890190     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00477-7     Document Type: Review

References (49)

1. Fazio F, Paganelli G. Antibody-guided scintigraphy: targeting of the "magic bullet". Eur J Nucl Med 1993, 20, 1138-1140.
2. Kim JA, Triozzi PL, Martin EW. Radioimmunoguided surgery for colorectal cancer. Oncology 1993, 7, 55-64.
3. Leichner PK, Koral KF, Jaszczak RJ, et al. An overview of immaging techniques and physical aspects of treatment planning in radioimmunotherapy. Med Physics 1993, 20, 569-577.
4. Chetanneau A, Barbet J, Peltier P, et al. Pretargetted imaging of colorectal cancer recurrences using an In-111-labelled bivalent hapten and a bispecific antibody conjugate. Nucl Med Commu 1994, 15, 972-980.
5. Hirai H. Use of tumor receptors for diagnostic imaging. Acta Radiol 1990, 374, 57-64.
6. Hazra DK, Britton KE, Lahiri VL, et al. Immunotechnological trend in radioimmuno-targeting: from 'magic bullet' to 'smart bomb'. Nucl Med Comm 1995, 16, 66-75.
7. Kuhn JA, Corbisiero RM, Buras RR, et al. Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer. Arch Surg 1991, 126, 1398-1403.
8. Schlom J. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1986, 46, 3225-3238.
9. Strand SE, Zanzonico P, Johnson TK. Pharmacokinetic modeling. Med Physics 1993, 20, 515-527.
10. Juweid M, Neumann R, Paik C, et al. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res 1992, 52, 5144-5153.
11. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 1975, 256, 495-497.
12. Epenetos AA, Snook D, Durbin H, et al. Limitations of radio-labeled monoclonal antibodies for localization of human neoplasms. Cancer Res 1986, 46, 3183-3191.
13. Serafini AN. From monoclonal antibodies to peptides and molecular recognition units: an overview. J Nucl Med 1993, 34, 533-536.
14. Haunschild J, Faro HP, Pack P, et al. Pharmacokinetic properties of bivalent miniantibodies and comparison to other immunoglobulin forms. Antibody, Inimunoconj Pharm 1995, 8, 111-128.
15. Holliger P, Prospero T, Winter G. "Diabodies": small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 1993, 90, 6444-6448.
16. Kobayashi H, Sakahara H, Hosono M, et al. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accummulation in the target tumor. J Nucl Med 1994, 35, 1677-1684.
17. Marshall D, Pedley RB, Boden JA, et al. Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model. Br J Cancer 1993, 69, 502-507.
18. Marshall D, Pedley RB, Melton RG, et al. Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab′)2 fragment of an anti-tumour antibody. Br J Cancer 1995, 71, 18-24.
19. Sinitsyn VV, Mamantova AG, Checkneva YY, et al. Rapid blood clearance of biotinylated IgG after infusion of avidin. J Nucl Med 1989, 30, 66-69.
20. Bos ES, Kuijpers WHA, Meesters-Winters M, et al. In vitro evaluation of DNA-DNA hybridization as a two-step approach in radioimmunotherapy of cancer. Cancer Res 1994, 54, 3479-3486.
21. Goodwin DA, Meares CF, McCall M, et al. Targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J Nucl Med 1988, 29, 226-234.
22. LeDoussal JM, Martin M, Gautherot E, et al. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate. J Nucl Med 1989, 30, 1358-1366.
23. Paganelli G, Riva P, Deleide G, et al. In vivo labelling of biotinylated monoclonal antibodies by radioactive avidin: a strategy to increase tumor radiolocalization. Int J Cancer 1988, 2, 121-125.
24. Paganelli G, Malcovati M, Fazio F. Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system. Nucl Med Commu 1991, 12, 211-234.
25. Paganelli G, Magnani P, Siccardi AG, et al. Clinical application of the avidin-biotin system for tumor targeting. In Goldenberg DM, ed. Cancer Therapy with Radiolabeled Antibodies. CRC Press, 1995, 239-254.
26. Schuhmacher J, Klivenyi G, Matys R, et al. Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography. Cancer Res 1995, 55, 115-123.
27. Sung C, Osdol WW. Pharamcokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin-biotin binding. J Nucl Med 1995, 36, 867-876.
28. Paganelli G, Pervez S, Siccardi A, et al. Intraperitoneal radio-localization of tumors pretargeted by biotinylated monoclonal antibodies. Int J Cancer 1990, 45, 1184-1189.
29. Saga T, Weinstein JN, Jeong JM, et al. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res 1994, 54, 2160-2165.
30. LeDoussal JM, Barbet J, Delaage M. Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results. Int J Cancer 1992, 7, 58-62.
31. Sung C, van Osdol WW, Saga T, et al. Streptavidin distribution in metastatic tumors pretargeted with a biotinylated monoclonal antibody: theoretical and experimental pharmacokinetics. Cancer Res 1994, 54, 2166-2175.
32. Suresh MR, Cuello AC, Milstein C. Bispecific monoclonal antibodies from hybrid hybridomas. Methods Enzymol 1986, 121, 210.
33. Stella M, DeNardi P, Paganelli G, et al. Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Dis Colon Rectum 1994, 37, 335-343.
34. Green NM. Avidin-1. The use of [14C] biotin for kinetic studies and for assay. Biochem J 1963, 89, 585.
35. Gitlin G, Bayer EA, Wilchek M. Studies on the biotin-binding sites of avidin and streptavidin. Biochem J 1990, 269, 527-530.
36. Schechter B, Silberman R, Arnon R, et al. Tissue distribution of avidin and streptavidin injected to mice. Eur J Biochem 1990, 89, 327-331.
37. Khwali LA, Alauddin MM, Miller GK, et al. Improved immunotargeting of tumors with biotinylated monoclonal antibodies and radiolabeled streptavidin. Antibody, Immunoconj Radiopharmaceuticals 1993, 6, 13-19.
38. Rosario RB, Wahl RL. Biotinylated iodo-polylysine for pretargeted radiation delivery. J Nucl Med 1993, 34, 1147-1151.
39. LeDoussal JM, Gautherot E, Martin M, et al. Enhanced in-vivo targeting of an asymmetric bivalent hapten to double-antigen-positive mouse B cells with monoclonal antibody conjugate cocktails. J Immun 1991, 146, 169-175.
40. Somasundaram C, Matzku S, Schumacher J, et al. Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphy. Cancer Immu Immunother 1993, 36, 337-345.
41. Chetanneau A, Barbet J, Peltier P, et al. Pretargetted imaging of colorectal cancer recurrences using an In-111-labelled bivalent hapten and a bispecific antibody conjugate. Nucl Med Commu 1994, 15, 972-980.
42. Hnatowich DN, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987, 28, 1294-1302.
43. Kobayashi H, Sakahara H, Endo K, et al. Repeating the avidin "chase" markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity. Eur J Cancer 1995, 31A, 1689-1696.
44. Kalofonos HP, Rusckowsk M, Siebecker DA, et al. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med 1990, 31, 1791-1796.
45. Grippa F, Buraggi GL, Di Re E, et al. Radioimmuno-scintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer 1991, 27, 724-729.
46. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res 1992, 51, 5960-5966.
47. Delaloye AB, Delaloye B. Tumor imaging with monoclonal antibodies. Semin Nucl Med 1995, 25, 144-164.
48. Paganelli G, Stella M, Zito F, et al. Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med 1994, 35, 1970-1975.
49. Magnani P, Paganelli G, Modorati G, et al. Immunoscintigraphy of uveal melanoma: a quantitative comparison of direct antibody labeling and tumor pretargeting. J Nucl Med, in press.